Aspect Partners’s Quest Diagnostics DGX Stock Holding History

Aspect Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.26K	Hold	14	–	–	﹤0.01%	469
2026 Q2	$2.97K	Hold	14	–	–	﹤0.01%	483
2026 Q1	$2.74K	Hold	14	–	–	﹤0.01%	440
2025 Q4	$2.43K	Buy	14 +3	+27%	+$546	﹤0.01%	494
2025 Q3	$2.1K	Hold	11	–	–	﹤0.01%	526
2025 Q2	$1.98K	Hold	11	–	–	﹤0.01%	474
2025 Q1	$1.86K	Hold	11	–	–	﹤0.01%	456
2024 Q4	$1.66K	Hold	11	–	–	﹤0.01%	490
2024 Q3	$1.71K	Hold	11	–	–	﹤0.01%	454
2024 Q2	$1.51K	Hold	11	–	–	﹤0.01%	477
2024 Q1	$1.46K	Sell	11 -1	-8%	-$130	﹤0.01%	468
2023 Q4	$1.66K	Buy	+12	New	+$1.58K	﹤0.01%	450

Other funds holding DGX

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return

Aspect Partners's DGX Position: Q3 2026 in Review

Aspect Partners held its Quest Diagnostics (DGX) position steady in Q3 2026 at 14 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Aspect Partners first reported a position in DGX in Q4 2023 and has held it in 12 quarters since. 266 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Aspect Partners held 14 shares of Quest Diagnostics worth $3.26K as of Q3 2026.
Aspect Partners left its Quest Diagnostics share count unchanged in Q3 2026.
Quest Diagnostics made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #469 holding.
Aspect Partners first reported a position in Quest Diagnostics in Q4 2023 and has held it in 12 quarters since.
266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.